The Opiate Antagonist, Naltrexone, in the Treatment of Trichotillomania

October 2013 in “ Journal of Clinical Psychopharmacology ”

Jon E. Grant, Brian L. Odlaug, Liana R.N. Schreiber, Suck Won Kim

New to Naltrexone? There is a guide in the encyclopedia. Read the guide →

naltrexone trichotillomania opioid antagonist hair pulling cognitive flexibility opiate system Revia TTM

Studysummary This study found that naltrexone did not significantly reduce hair pulling in adults with trichotillomania compared to placebo, although it improved cognitive flexibility.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on journals.lww.com →

Discuss this study in the Community →

Similar Research

5 / 1000+ results

research Trichotillomania Successfully Treated With Risperidone and Naltrexone: A Geriatric Case Report

13 citations , March 2014 in “Journal of the American Medical Directors Association”

This review discusses the characteristics, prevalence, and treatment challenges of trichotillomania and provides no new clinical findings.

research Low-dose naltrexone: a novel adjunctive treatment in symptomatic alopecias?

4 citations , January 2019 in “Dermatology Online Journal”

This article discusses the potential of low-dose naltrexone as an adjuvant therapy for trichodynia in alopecias, noting its anti-inflammatory properties and need for further research.

research Recent advances in the treatment of trichotillomania (hair‐pulling disorder)

24 citations , June 2020 in “Dermatologic Therapy”

This review discusses recent advances in the pharmacological treatment of trichotillomania, highlighting potential benefits of glutamate-modulating agents, and reports no new clinical results.

research Actualización en el tratamiento de la tricotilomanía

November 2024 in “Actas Dermo-Sifiliográficas”

This review outlines current treatment strategies for trichotillomania, noting that while cognitive-behavioral therapy is effective, N-acetylcysteine and memantine are also recommended due to their safety and efficacy, though evidence for other drugs like fluoxetine and naltrexone remains limited.

research Trichotillomania.

April 2016 in “Apollo (University of Cambridge)”

This article reviews treatment approaches for trichotillomania, emphasizing differences from OCD therapies and recommending specific management strategies, without providing new experimental findings.